Perspectives on organic agriculture and new plant breeding techniques

Publication date: 08/11/2017

The organic industry has vocally rejected genetically-modified crops (GMOs), making a public declaration in 1993 that they are incompatible with organic agriculture.

Since then, many organic supporters have campaigned against GMOs, and organic farming regulations in the EU and beyond prohibit their use.

Emerging genetic technologies have sparked renewed interest in this debate, but policy makers are still undecided on whether they should be subject to the same extensive regulations as genetic modification. Within the organic industry, there are different perspectives on whether these new techniques could ever be compatible with organic food production.

In this blog-post Rebecca Nesbit gives us an insight into these differing perspectives, interviewing proponents from each side.

Resource type: article: Web Page

Why are NGOs sceptical of genome editing?

Publication date: 02/11/2017

In 2016, 107 Nobel Laureates signed an open letter calling on Greenpeace to desist from campaigning against agricultural biotechnology and for governments to reject and resist such campaigning, arguing that “[o]pposition based on emotion and dogma contradicted by data must be stopped”

The letter marked the latest chapter in a long‐running, heated and apparently intractable debate around agricultural biotechnology. Yet, while the arguments by Greenpeace and other non‐governmental organisations (NGOs) against agricultural biotechnology are frequently dismissed as based on emotion and dogma, their opposition is often grounded on more general scepticisms concerning the framing of the problem and its solutions, and the motivations of actors to employ biotechnology in agriculture.

Genome editing is an important case of agricultural biotechnology. In Europe, however, the European Commission has been delaying a decision on the regulation of genome editing and new plant breeding techniques (NPBT) for use in agriculture.

In the meantime, numerous groups are attempting to influence the debate, including biotechnology companies, scientists and NGOs. Scientists and their representations have been particularly prominent in these debates in contrast to a more muted position from commercial interests as companies have adopted a “wait‐and‐see” strategy with regard to the pending regulatory decision on genome editing.

As with earlier debates on genetically modified (GM) crops, NGOs have become the subject of intense criticism from leading scientists who support genome editing in agriculture. The subsequent debates have aroused passions on all sides, but rarely led to greater mutual understanding.

In this paper, we use the case of genome editing to argue that the Nobel Laureate letter may have mischaracterised opposition to agricultural biotechnology as rooted in emotion and dogma.

Rather, our results suggest that this opposition is grounded in three specific types of scepticism concerning the problem framing of food security; the focus on intensive agriculture and technological solutions to the problem of food security; and the motivations for adopting agricultural biotechnology. Below, we describe our methods for analysing NGO scepticism, before providing more detail on each of three types of scepticism.

Resource type: Adobe Acrobat (.pdf)

New genetic engineering techniques: precaution, risk, and the need to develop prior societal technology assessment

Publication date: 18/08/2017

Business has been arguing that governments should override the precautionary principle in favor of an “innovation principle.” The new genetic engineering techniques (sometimes called “new breeding techniques”)1 provide the perfect cover for this argument. Proponents assure us that these new techniques are essential to address the crises we face and will provide economic benefit, as long as we set aside the precautionary approach that they claim increasingly hampers technological progress. We are in the midst of powerful high-risk technological developments with potentially severe and irreversible health, environmental, and societal implications. It is vital to develop processes for examining new technologies while they are still being developed. We argue that precaution needs to guide technology development in this area. Indeed, it should precede the technology development. An adequate technology assessment and decision-making process requires concerted effort, courage, and restraint, and it must include the option to decide against developing or deploying some technologies altogether.

Resource type: Adobe Acrobat (.pdf)

Is it only the regulatory status? Broadening the debate on cisgenic plants

Publication date: 26/06/2017

In current debates on emerging technologies for plant breeding in Europe, much attention has been given to the regulatory status of these techniques and their public acceptance. At present, both genetically modified plants with cisgenic approaches—using genes from crossable species—as well as transgenic approaches—using genes from different species—fall under GMO regulation in the EU and both are mandatorily labelled as GMOs. Researchers involved in the early development of cisgenic GM plants convey the message that the potential use and acceptance of cisgenic approaches will be seriously hindered if GMO regulations are not adjusted.

Although the similar treatment and labelling of transgenic and cisgenic plants may be a legitimate concern for the marketability of a cisgenic GM plant, there are concerns around their commercialization that reach beyond the current focus on (de)regulation. In this paper, we will use the development of the cisgenic GM potato that aims to overcome ‘late blight’—the most devastating potato disease worldwide—as a case to argue that it is important to recognize, reflect and respond to broader concerns than the dominant focus on the regulatory ‘burden’ and consumer acceptance. Based on insights we gained from discussing this case with diverse stakeholders within the agricultural sector and potato production in Norway during a series of workshops, we elaborate on additional issues such as the (technical) solution offered; different understandings of the late blight problem; the durability of the potato plant resistance; and patenting and ownership.

Hence, this paper contributes to empirical knowledge on stakeholder perspectives on emerging plant breeding technologies, underscoring the importance to broaden the scope of the debate on the opportunities and challenges of agricultural biotechnologies, such as cisgenic GM plants. The paper offers policy-relevant input to ongoing efforts to broaden the scope of risk assessments of agricultural biotechnologies. We aim to contribute to the recognition of the complex socio-ecological, legal and political dimensions in which these technological developments are entangled as a means to acknowledge, discuss and respond to these concerns and thereby contribute to more comprehensive and responsible developments within agricultural biotechnology.

Resource type: Adobe Acrobat (.pdf)

Addressing socio-economic and ethical considerations in biotechnology governance: the potential of a new politics of care

Publication date: 01/06/2017

There is a growing demand to incorporate social, economic and ethical considerations into biotechnology governance. However, there is currently little guidance available for understanding what this means or how it should be done.

A framework of care-based ethics and politics can capture many of the concerns maintaining a persistent socio-political conflict over biotechnologies and provide a novel way to incorporate such considerations into regulatory assessments. A care-based approach to ethics and politics has six key defining features.

These include: 1) a relational worldview, 2) an emphasis on the importance of context, 3) a recognition of the significance of dependence, 4) an analysis of power, including a particular concern for those most vulnerable, 5) a granting of weight to the significance of affect, and 6) an acknowledgment of an important role for narrative. This policy brief provides an overview of these defining features, illustrates how they can appear in a real world example and provides a list of guiding questions for assessing these features and advancing a politics of care in the governance of biotechnology

Resource type: Adobe Acrobat (.pdf)

Forcing consensus is bad for science and society

Publication date: 12/05/2017

The March for Science that took place in cities around the world on April 22 was intended to “speak for science”, defending evidence-based policies, the strength of peer-reviewed facts and government-funded research.

The marches reflect a growing trend. In February 2017, the text Ethics & Principles for Science & Society Policy-Making, known as the Brussels declaration, was adopted at the American Association for the Advancement of Science’s annual meeting, in Boston. And both the OECD and UNESCO have recently published documents supporting the role of science in informing policy.

Open dialogue between scientists and the societies in which they live and work is, of course, an essential ingredient of democracy. But insisting that science operate under a mandate of consensus, which is the timbre of numerous debates, from vaccines to climate change to genetically modified organisms (GMOs), is not.

Faux unanimity in science actually underexposes policy-relevant scientific and political dissent.

The risks of scientism

Critics of the March for Science, ourselves included, have noted that the march’s program is dangerously close to “scientism” – the adoption of science as a worldview or a religion to the exclusion of other viewpoints.

In doing so, both the march and agreements such as the Brussels declaration ignore the deep crisis facing science, with its daily bulletin of casualties.

Nor is it a good sign that few are reflecting on the power asymmetries that taints what science is used in policy: citizens can’t easily create scientific knowledge, while corporate interests can and do. And evidence has become a currency used by lobbies to purchase political influence.

On the issue of climate change, most scientists have likely formed the opinion that humanity is basically conducting a large-scale geophysical experiment with the planet by increasing the concentration of greenhouse gases.

The problem is not that thesis (it’s essentially correct) but that it is been presented as the scientific consensus concerning the proposed strategy for phasing out fossil fuels. Reasonable minds can differ on the urgency or the feasibility of the strategy for mitigating global warming.

This is one reason why observers on both sides of the “act now!” versus “wait and see” camps can’t agree on how to tame the doubt hounding both climate research and effective responses to the challenge.

What climate, vaccines and GMOs have in common

Childhood vaccination is another hotly contested topic, and the controversy around them has flared for two decades. It started with a paper published in The Lancet in 1998 – later retracted – that purported to show links between vaccines and autism.

The controversy is as fierce as ever today thanks to the involvement of US President Donald Trump and his entourage.

We support vaccination. But we cannot overlook that science holds the responsibility for both starting the scare and for taking a long time to correct its errors. It is unfortunate that we (and others) need to exhibit pro-vaccine credentials in order to attempt a meaningful discussion.

It is also regrettable that vaccines end up being mentioned in same sentence as climate and GMOs. The frequent implication is that science is not the problem but rather the people, who, lacking the knowledge necessary to formulate a clear judgement, end up resisting scientific facts.

This perpetuates the so-called deficit model, an old theory that blames the lay public’s ignorance of science for many problems in the adoption of evidence-based policies.

Golden rice and crimes against humanity

Should science speak with one voice? It did, without doubt, last year when 107 Nobel laureates signed an open letter accusing the environment organisation Greenpeace of crimes against humanity for delaying the commercialisation of a genetically modified rice variety called golden rice.

The Nobel laureates argued that golden rice, which is high in beta carotene, has the potential to “reduce or eliminate much of the death and disease caused by a vitamin A deficiency” and possibly avoid the one to two million “preventable deaths [that] occur annually as a result of this nutritional imbalance”.

Some observers stressed the gravity of the accusations, while prominent journals such as Science and Nature downplayed the letter.

Either way, its content is, frankly, incendiary (more extracts here). In addition to the above claims, the laureates asserted that Greenpeace has “spearheaded opposition” to golden rice. “Opposition based on emotion and dogma contradicted by data must be stopped”, they wrote. “How many poor people in the world must die before we consider this a ‘crime against humanity’?”

Many claims in the letter are either patently false or highly contended. Even the thesis that golden rice is an instrument in the battle against vitamin A deficiency is questionable, according to the International Rice Research Institute. The enhanced beta carotene content of the crop appears to be variable and its value possibly reduced by cooking. Its effectiveness merits further study.

Other scientists have pointed out that vitamin deficiencies are more efficiently fought with better nutrition, direct supplementation, nutrition education programs, the promotion of home gardens, or with the enrichment of staple food with essential nutrients such as vitamin A. All these policies have been implemented successfully over the past decade in many countries.

Golden rice is also a poor solution for vitamin A deficiency because of its lower yield compared to other rice varieties, which could deter farmers from growing it. This is one of the reasons why golden rice is not yet approved for commercialisation.

Finally, its yellow colour makes it more difficult to detect contamination from a dangerous mycotoxin that can cause serious health problems in humans.

All of which is to say that claiming that the introduction of the crop in Asia and Africa by early 2000 would have been beneficial and saved lives is doubtful at best. The evidence does not even contradict the alternative conclusion: that the delayed commercialisation was actually better for the populations concerned.

Safe or fair?

GMOs are a battlefield showing how the issue of framing – deciding on the nature of the problem – is of paramount importance.

For two decades, we have been told that GMOs are safe for human consumption. The tunnel vision on food safety has led to the neglect of other legitimate inquiries on, say, issues of the power, regulation and control of the genetic fabric of our food. Such issues are central to why many constituencies opposed GMO crops.

Relevant, too, and also under discussed, are lessons from unsuccessful GMO adoption.

Today, increasingly more voices are asserting that new technologies should be regulated not only on their benefit-risk profiles but also on their societal context and need, and searching The Conversation for “golden rice” returns a wealth of opinions, indeed – the opposite of a consensus.

This happens because science is a “show me”, not a “trust me”, field. Purporting to speak on behalf of all science, as the Nobel laureates sought to do with golden rice, conflated science, the scientific method and truth.

We live in times of intense ideological confrontations surrounding scientific work. The notion that science works for a common good, which is occasionally imbued with the prestige and authority of Nobel Prize winners, is reassuring. But it is dangerous.

“Science is strictly impersonal; a method and a body of knowledge,” wrote the sociologist John Dewey in the 1930s. “It owes its operation and its consequences to the human beings who use it. It adapts itself passively to the purposes and desires which animate these human beings.”

Dewey called the problem involved in our control of science “the greatest which civilisation has ever had to face”. This calls for a vigilant society and a scientific field that never tires of being critical of itself.

 

This article first appeared in The Conversation and is reprinted here with permission.

Resource type: Word Document (.doc)

A world without hunger: organic or GM crops?

Publication date: 11/04/2017

It has been estimated that the world population will increase to 9.2 billion by 2050; supplying the growing population with food will require a significant increase in agricultural production.

A number of agricultural and ecological scientists believe that a large-scale shift to organic farming (OF) would not only increase the world’s food supply, but might be the only way to eradicate hunger sustainably.

Nevertheless, OF has recently come under new scrutiny, not just from critics who fear that a large-scale shift in this direction would cause billions to starve but also from farmers and development agencies who question whether such a shift could improve food security. Meanwhile, the use of genetically modified (GM) crops is growing around the world, leading to possible opportunities to combat food insecurity and hunger. However, the development of GM crops has been a matter of considerable interest and worldwide public controversy.

So far, no one has comprehensively analyzed whether a widespread shift to OF or GM would be the sole solution for both food security and safety. Using a literature review from databases of peer-reviewed scientific publications, books, and official publications, this study aims to address this issue.

Results indicate that OF and GM, to different extents, are able to ensure food security and safety. In developed countries, given that there are relatively few farmers and that their productivity, even without GMOs, is relatively high, OF could be more a viable option.

However, OF is significantly less efficient in land-use terms and may lead to more land being used for agriculture due to its lower yield. In developing countries, where many small-scale farmers have low agricultural productivity and limited access to agricultural technologies and information, an approach with both GM and OF might be a more realistic approach to ensure food security and safety.

Link goes to full text and .pdf options.

Resource type: Web page URL

Not just about “the science” – science education and attitudes to genetically modified foods among women in Australia

Publication date: 08/02/2017

Previous studies investigating attitudes to genetically modified (GM) foods suggest a correlation between negative attitudes and low levels of science education, both of which are associated with women.

In a qualitative focus group study of Australian women with diverse levels of education, we found attitudes to GM foods were part of a complex process of making “good” food decisions, which included other factors such as locally produced, fresh/natural, healthy and nutritious, and convenient. Women involved in GM crop development and those with health science training differed in how they used evidence to categorize GM foods.

Our findings contribute to a deeper understanding of how GM food, and the role of science and technology in food production and consumption more broadly, is understood and discussed amongst diverse “publics” and across different “sciences,” and to research related to deepening public engagement at the intersection of science and values.

Resource type: Web page URL

Sowing fresh seeds – Food, farming and animal welfare post-Brexit

Publication date: 31/01/2017

Brexit gives us the opportunity to think about food and farming from scratch. We need food and farming that produces nutritious food and encourages healthy diets. That enables us to
meet the Paris climate targets and restores water, soils and biodiversity so that they are passed in good shape to future generations. Decent livelihoods for farmers and respect for
animals as sentient beings, as individuals must be core elements of our policy.

There are two important starting points. Firstly, we need to move away from the current practice of formulating policy in silos with different Government departments, or sections of
departments, being responsible for agriculture, the environment, animal welfare, dietary health, climate change and agri-tech. As a result policies in this arena do not cohere and are
sometimes contradictory. For example, Defra tends to press for further intensification even though this has a detrimental impact on soil quality and animal welfare. Public Health
England advises people to eat less red and processed meat while Defra promotes increased meat production.

Secondly, we need to move away from industrial livestock production as this is a key driver of, or an important contributor to:

  • overconsumption of meat and dairy which leads to health problems and will make it
    impossible to meet the Paris climate targets
  • overuse of antibiotics in farming
  • pollution and overuse of water, soil degradation, biodiversity loss and air pollution
  • food insecurity
  • poor animal welfare

Compassion in World Farming  wishes to present the following integrated plan for post Brexit food and farming in England.

Resource type: Adobe Acrobat (.pdf)

Concepts and strategies of organic plant breeding in light of novel breeding techniques

Publication date: 23/12/2016

In this paper, we describe the development of a set of guiding principles for the evaluation of breeding techniques by the organic sector over time. The worldwide standards of organic agriculture (OA) do not allow genetic engineering (GE) or any products derived from genetic engineering. The standards in OA are an expression of the underlying principles of health, ecology, fairness and care. The derived norms are process and not product oriented. As breeding is considered part of the process in agriculture, GE is not a neutral tool for the organic sector. The incompatibility between OA and GE is analyzed, including the “novel breeding techniques”. Instead, alternative breeding approaches are pursued based on the norms and values of organic agriculture not only on the technical level but also on the social and organizational level by including other value chain players and consumers. The status and future perspectives of the alternative directions for organic breeding are described and discussed.

Resource type: Adobe Acrobat (.pdf)